Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial (Q45295447)
Jump to navigation
Jump to search
scientific article published in January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial |
scientific article published in January 2013 |
Statements
1 reference
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial (English)
1 reference
M Nauck
1 reference
E Horton
1 reference
M Andjelkovic
1 reference
F J Ampudia-Blasco
1 reference
C T Parusel
1 reference
M Boldrin
1 reference
R Balena
1 reference
T-emerge 5 Study Group
1 reference
1 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference